Latest period
-$952M
YoY change
+37.1%
5Y CAGR
—
Peak year (FY2010)
-$989K
Latest annual
-$968M
Free Cash Flow history chart for Insmed (INSM) from 2016 to 2025
Latest: -$968M
Free Cash Flow growth chart for Insmed (INSM) from 2016 to 2025
Latest: +37.1%
Free Cash Flow history table for Insmed (INSM) from 1999 to 2025
| FY2025 | -$968M | +37.1% | -$262M | ||
| FY2024 | -$706M | +28.4% | -$156M | ||
| FY2023 | -$550M | +33.9% | -$139M | ||
| FY2022 | -$410M | +10.7% | -$39.7M | ||
| FY2021 | -$371M | +63.9% | -$144M | ||
| FY2020 | -$226M | -22.8% | +$66.7M | ||
| FY2019 | -$293M | +7.4% | -$20.1M | ||
| FY2018 | -$273M | +67.7% | -$110M | ||
| FY2017 | -$163M | +7.8% | -$11.7M | ||
| FY2016 | -$151M | +44.9% | -$46.8M | ||
| FY2015 | -$104M | +49.3% | -$34.4M | ||
| FY2014 | -$69.8M | +46.9% | -$22.3M | ||
| FY2013 | -$47.5M | +51.7% | -$16.2M | ||
| FY2012 | -$31.3M | +0.4% | -$118K | ||
| FY2011 | -$31.2M | +3053.1% | -$30.2M | ||
| FY2010 | -$989K | -91.0% | +$10M | ||
| FY2009 | -$11M | -8.2% | +$980K | ||
| FY2008 | -$12M | -52.5% | +$13.3M | ||
| FY2007 | -$25.3M | -46.5% | +$22M | ||
| FY2006 | -$47.2M | +70.1% | -$19.5M | ||
| FY2005 | -$27.8M | +11.5% | -$2.86M | ||
| FY2004 | -$24.9M | +131.4% | -$14.1M | ||
| FY2003 | -$10.8M | -55.8% | +$13.6M | ||
| FY2002 | -$24.3M | -24.0% | +$7.7M | ||
| FY2001 | -$32M | +41.0% | -$9.32M | ||
| FY2000 | -$22.7M | +209.3% | -$15.4M | ||
| FY1999 | -$7.34M | — | — |
- FY2025-$968M+37.1%
- FY2024-$706M+28.4%
- FY2023-$550M+33.9%
- FY2022-$410M+10.7%
- FY2021-$371M+63.9%
- FY2020-$226M-22.8%
- FY2019-$293M+7.4%
- FY2018-$273M+67.7%
- FY2017-$163M+7.8%
- FY2016-$151M+44.9%
- FY2015-$104M+49.3%
- FY2014-$69.8M+46.9%
- FY2013-$47.5M+51.7%
- FY2012-$31.3M+0.4%
- FY2011-$31.2M+3053.1%
- FY2010-$989K-91.0%
- FY2009-$11M-8.2%
- FY2008-$12M-52.5%
- FY2007-$25.3M-46.5%
- FY2006-$47.2M+70.1%
- FY2005-$27.8M+11.5%
- FY2004-$24.9M+131.4%
- FY2003-$10.8M-55.8%
- FY2002-$24.3M-24.0%
- FY2001-$32M+41.0%
- FY2000-$22.7M+209.3%
- FY1999-$7.34M—
Free Cash Flow values are taken from Insmed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Insmed (INSM)
Free Cash Flow for Insmed (INSM): headline value -$952M · YoY +37.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Insmed (INSM) came in at -$968M – surged 37.1% year-over-year.
-$989K stands as the all-time-high annual free cash flow, posted in 2010, against a low of -$968M during 2025.
Insmed Free Cash Flow by Year
Insmed Free Cash Flow 2025: -$968M
Insmed posted free cash flow of -$968M in 2025, surged 37.1% from 2024. This figure represents the lowest annual value in the available history.
Insmed Free Cash Flow 2024: -$706M
In 2024, Insmed reported free cash flow of -$706M, grew 28.4% from 2023.
Insmed Free Cash Flow 2023: -$550M
Insmed free cash flow in 2023 was -$550M, surged 33.9% from 2022.
Insmed Free Cash Flow 2022: -$410M
2022's free cash flow for Insmed came in at -$410M, grew 10.7% from 2021.
Insmed Free Cash Flow 2021: -$371M
Insmed free cash flow in 2021 was -$371M.
See more financial history for Insmed (INSM).
Sector peers by Free Cash Flow
Healthcare peers of Insmed (INSM), ranked by their latest free cash flow
| $19.7B | |
| $17.8B | |
| $16.1B | |
| $12.4B | |
| $8.97B | |
| $8.1B | |
| $6.29B | |
| $4.52B |
- $19.7B
- $17.8B
- $16.1B
- $12.4B
- $8.97B
- $8.1B
- $4.52B
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.